In conclusion, selective activation of TLR signaling pathways within the CNS that induces IFNβ production and recruitment of peripheral cells may have therapeutic potential in inflammatory demyelinating diseases such as MS (Figure 7). The gene discussed is IFNB1; the disease is myeloid sarcoma.